Particle Health says data dispute with Epic Systems not affecting most customers

Particle Health says data dispute with Epic Systems not affecting most customers


Joos Mind | Photodisc | Getty Images

Particle Health said on Monday that the “vast majority” of its customers are still receiving records from medical software giant Epic Systems despite an ongoing dispute between the two companies over data-sharing practices.

Epic’s software supports more than 300 million patient records, and Particle acts like a middleman that helps health-care organizations access the data they need. Both companies belong to an interoperability network called Carequality, which facilitates the exchange of patient information on a large scale.

On March 21, Epic filed a formal dispute with Carequality citing concerns that Particle and its participant organizations “might be inaccurately representing the purpose associated with their record retrievals.” In order to join the Carequality network, organizations are approved and must abide by “Permitted Purposes,” generally having to do with treatment, for the exchange of patient records

Patient data is protected by a federal law called the Health Insurance Portability and Accountability Act, or HIPAA, which requires a patient’s consent or knowledge for third-party access.

Particle said in a release Monday that while Epic “indiscriminately stopped responding” to data requests from some of its customers because of the dispute, most clients were not affected. The company said it’s been pressing Epic to restore connection to impacted customers, and many are already back to normal.

“While there is an ongoing dispute between Epic and Particle Health, related to three specific customers, the significant majority of Particle Health customers impacted by Epic’s actions were not in any way related to this dispute,” the company said in the release.

Particle CEO Jason Prestinario said in the statement that the company will address the dispute with Epic through official procedural channels.

Epic did not immediately respond to CNBC’s request for comment.

WATCH: Insurer stocks fall on Medicare rates

Health care stocks headed for worst day since early November



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More